Nxera Pharma UK Limited

Quick facts

Phase 1 pipeline

• HTL0009936
• HTL0009936 immediate release
• HTL0009936 modified release
• HTL0014242
• HTL0016878
• HTL0016878.HCl Solution 10 mg
• HTL0030310

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Nxera Pharma UK Limited portfolio CI brief
• Nxera Pharma UK Limited pipeline updates RSS